Advertisement

Topics

Novartis vows to fight U.S. price-fixing claims against Sandoz unit

01:34 EDT 13 May 2019 | Reuters

Novartis on Monday said claims of price fixing against its Sandoz generics unit amid a U.S. probe of 20 drugmakers are without merit, with the Swiss company vowing to fight allegations in a lawsuit filed last week.

Original Article: Novartis vows to fight U.S. price-fixing claims against Sandoz unit

NEXT ARTICLE

More From BioPortfolio on "Novartis vows to fight U.S. price-fixing claims against Sandoz unit"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...